M C Chillon
Overview
Explore the profile of M C Chillon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nino-Ramirez J, Alcoceba M, Gutierrez-Zufiaurre M, Marcos M, Gil-Etayo F, Bartol-Sanchez M, et al.
HLA
. 2024 Aug;
104(2):e15640.
PMID: 39148254
The pathogenesis of COVID-19 warrants unravelling. Genetic polymorphism analysis may help answer the variability in disease outcome. To determine the role of KIR and HLA polymorphisms in susceptibility, progression, and...
2.
Boix F, Feito J, Rodriguez-Campon A, Chillon M, Garcia-Sanchez S, Tabernero G, et al.
Br J Biomed Sci
. 2021 Jun;
78(4):244-247.
PMID: 34105441
Mixed acute rejection is a clinicopathological entity that is difficult to accurately diagnose, and so may be under-reported. Allografts are lost more often than in either humoral or cellular rejection....
3.
Pfeifer H, Cazzaniga G, van der Velden V, Cayuela J, Schafer B, Spinelli O, et al.
Leukemia
. 2020 Jan;
34(7):1970.
PMID: 31937894
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
4.
Pfeifer H, Cazzaniga G, van der Velden V, Cayuela J, Schafer B, Spinelli O, et al.
Leukemia
. 2019 Mar;
33(8):1910-1922.
PMID: 30858550
Minimal residual disease (MRD) is a powerful prognostic factor in acute lymphoblastic leukemia (ALL) and is used for patient stratification and treatment decisions, but its precise role in Philadelphia chromosome...
5.
Jimenez C, Alonso-Alvarez S, Alcoceba M, Ordonez G, Garcia-Alvarez M, Prieto-Conde M, et al.
Blood Cancer J
. 2017 Aug;
7(8):e591.
PMID: 28841204
Transformation of Waldenström's macroglobulinemia (WM) to diffuse large B-cell lymphoma (DLBCL) occurs in up to 10% of patients and is associated with an adverse outcome. Here we performed the first...
6.
Chillon M, Jimenez C, Garcia-Sanz R, Alcoceba M, Prieto I, Garcia-Alvarez M, et al.
Ann Hematol
. 2017 Aug;
96(10):1699-1705.
PMID: 28770277
Chromosome 1q gains and 13q deletions are common cytogenetic aberrations in multiple myeloma (MM) that confer a poor prognosis. There are several techniques for the targeted study of these alterations,...
7.
Jovanovic J, Chillon M, Vincent-Fabert C, Dillon R, Voisset E, Gutierrez N, et al.
Leukemia
. 2016 Nov;
31(3):747-751.
PMID: 27872498
No abstract available.
8.
Bueno C, Sardina J, Di Stefano B, Romero-Moya D, Munoz-Lopez A, Ariza L, et al.
Leukemia
. 2015 Oct;
30(3):674-82.
PMID: 26500142
B cells have been shown to be refractory to reprogramming and B-cell-derived induced pluripotent stem cells (iPSC) have only been generated from murine B cells engineered to carry doxycycline-inducible Oct4,...
9.
Puig N, Conde I, Jimenez C, Sarasquete M, Balanzategui A, Alcoceba M, et al.
Leukemia
. 2015 Jan;
29(6):1435-7.
PMID: 25567133
No abstract available.
10.
Puig N, Sarasquete M, Balanzategui A, Martinez J, Paiva B, Garcia H, et al.
Leukemia
. 2013 Jul;
28(2):391-7.
PMID: 23860448
We have analyzed the applicability, sensitivity and prognostic value of allele-specific oligonucleotide real-time quantitative PCR (ASO RQ-PCR) as a method for minimal residual disease (MRD) assessment in patients with multiple...